Silence Therapeutics Plc (SLNCF)
5.50
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Silence Therapeutics Price to Book Value : 20.26 for Aug. 21, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 20.26 |
| August 20, 2026 | 20.26 |
| August 19, 2026 | 20.26 |
| August 18, 2026 | 20.26 |
| August 17, 2026 | 22.07 |
| August 14, 2026 | 22.07 |
| August 13, 2026 | 22.07 |
| August 12, 2026 | 22.07 |
| August 11, 2026 | 16.86 |
| August 10, 2026 | 16.58 |
| August 07, 2026 | 5.526 |
| August 06, 2026 | 5.526 |
| August 05, 2026 | 5.526 |
| August 04, 2026 | 5.526 |
| August 03, 2026 | 5.526 |
| July 31, 2026 | 5.526 |
| July 30, 2026 | 5.526 |
| July 29, 2026 | 5.526 |
| July 28, 2026 | 5.526 |
| July 27, 2026 | 5.526 |
| July 24, 2026 | 5.526 |
| July 23, 2026 | 5.526 |
| July 22, 2026 | 5.526 |
| July 21, 2026 | 5.526 |
| July 20, 2026 | 5.526 |
| Date | Value |
|---|---|
| July 17, 2026 | 5.526 |
| July 16, 2026 | 5.526 |
| July 15, 2026 | 5.526 |
| July 14, 2026 | 5.526 |
| July 13, 2026 | 5.526 |
| July 10, 2026 | 5.526 |
| July 09, 2026 | 5.526 |
| July 08, 2026 | 5.526 |
| July 07, 2026 | 5.526 |
| July 06, 2026 | 5.526 |
| July 02, 2026 | 5.526 |
| July 01, 2026 | 8.106 |
| June 30, 2026 | 8.106 |
| June 29, 2026 | 6.310 |
| June 26, 2026 | 6.310 |
| June 25, 2026 | 6.310 |
| June 24, 2026 | 6.310 |
| June 23, 2026 | 6.310 |
| June 22, 2026 | 6.310 |
| June 18, 2026 | 6.339 |
| June 17, 2026 | 6.339 |
| June 16, 2026 | 6.339 |
| June 15, 2026 | 6.339 |
| June 12, 2026 | 3.040 |
| June 11, 2026 | 3.040 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 39.20 |
| Mereo BioPharma Group Plc | 1.621 |
| Compass Pathways Plc | 22.80 |
| HemoGenyx Pharmaceuticals Plc | -- |
Price to Book Value Related Metrics
| PS Ratio | 1267.27 |
| Price | 5.50 |
| Earnings Yield | -7.69% |
| Market Cap | 779.57M |